Virus-host interactomes--antiviral drug discovery

Curr Opin Virol. 2012 Oct;2(5):614-21. doi: 10.1016/j.coviro.2012.09.003.

Abstract

One of the key questions in virology is how viruses, encoding relatively few genes, gain temporary or constant control over their hosts. To understand pathogenicity of a virus it is important to gain knowledge on the function of the individual viral proteins in the host cell, on their interactions with viral and cellular proteins and on the consequences of these interactions on cellular signaling pathways. A combination of transcriptomics, proteomics, high-throughput technologies and the bioinformatical analysis of the respective data help to elucidate specific cellular antiviral drug target candidates. In addition, viral and human interactome analyses indicate that different viruses target common, central human proteins for entering cellular signaling pathways and machineries which might constitute powerful broad-spectrum antiviral targets.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Drug Evaluation, Preclinical
  • Host-Pathogen Interactions / drug effects*
  • Humans
  • Protein Interaction Maps / drug effects
  • Viral Proteins / genetics
  • Viral Proteins / metabolism*
  • Virus Diseases / genetics
  • Virus Diseases / metabolism*
  • Virus Diseases / virology
  • Viruses / drug effects*
  • Viruses / genetics
  • Viruses / metabolism

Substances

  • Antiviral Agents
  • Viral Proteins